Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biodesix (BDSX) Intangibles: 2019-2025

Historic Intangibles for Biodesix (BDSX) over the last 5 years, with Sep 2025 value amounting to $19.0 million.

  • Biodesix's Intangibles fell 0.29% to $19.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $19.0 million, marking a year-over-year decrease of 0.29%. This contributed to the annual value of $19.0 million for FY2024, which is 0.18% down from last year.
  • According to the latest figures from Q3 2025, Biodesix's Intangibles is $19.0 million, which was up 0.02% from $19.0 million recorded in Q2 2025.
  • Biodesix's 5-year Intangibles high stood at $19.0 million for Q3 2024, and its period low was $18.5 million during Q1 2021.
  • Moreover, its 3-year median value for Intangibles was $19.0 million (2025), whereas its average is $19.0 million.
  • As far as peak fluctuations go, Biodesix's Intangibles spiked by 36.42% in 2021, and later fell by 0.29% in 2025.
  • Over the past 5 years, Biodesix's Intangibles (Quarterly) stood at $18.8 million in 2021, then climbed by 0.74% to $18.9 million in 2022, then grew by 0.51% to $19.0 million in 2023, then dropped by 0.18% to $19.0 million in 2024, then dropped by 0.29% to $19.0 million in 2025.
  • Its Intangibles was $19.0 million in Q3 2025, compared to $19.0 million in Q2 2025 and $18.9 million in Q1 2025.